Literature DB >> 8669462

Effects of mutation and growth rates on patterns of microsatellite instability.

Z H Li1, L A Aaltonen, Q Shu, S Srivastava, W E Grizzle, D Shibata.   

Abstract

The detection of somatic microsatellite (MS) alterations in tumors is often interpreted as a sign of underlying genomic instability. However, it is unclear why the proportions of altered MS loci vary between different mutator phenotype tumors. We present a simple mathematical analysis that can account for some of these differences, recognizing that the mutations accumulated in a tumor reflect both its mutation rate and number of cell divisions. Only a small proportion of mutated MS loci are expected in tumors with normal or low mutation rates. In contrast, tumors with high mutation rates may or may not acquire mutations depending on the numbers of divisions that proceed the onset of the mutator phenotype. The majority of MS loci should accumulate mutations if high mutation rates are acquired early in tumor progression. Somatic MS mutations provide clues to both the mode and tempo of tumori-genesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8669462      PMCID: PMC1861626     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Founding mutations and Alu-mediated recombination in hereditary colon cancer.

Authors:  M Nyström-Lahti; P Kristo; N C Nicolaides; S Y Chang; L A Aaltonen; A L Moisio; H J Järvinen; J P Mecklin; K W Kinzler; B Vogelstein
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

2.  Mutation of human short tandem repeats.

Authors:  J L Weber; C Wong
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

3.  Cell loss as a factor in the growth rate of human tumours.

Authors:  G G Steel
Journal:  Eur J Cancer       Date:  1967-11       Impact factor: 9.162

4.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

5.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

7.  A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene.

Authors:  L Spirio; G Joslyn; L Nelson; M Leppert; R White
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

8.  Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

Authors:  R A Lothe; P Peltomäki; G I Meling; L A Aaltonen; M Nyström-Lahti; L Pylkkänen; K Heimdal; T I Andersen; P Møller; T O Rognum
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

9.  Heterogeneity of malignant cells from a human colonic carcinoma.

Authors:  M G Brattain; W D Fine; F M Khaled; J Thompson; D E Brattain
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.

Authors:  Y Ionov; M A Peinado; S Malkhosyan; D Shibata; M Perucho
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

View more
  3 in total

1.  Intestinal stem cell division and genetic diversity. A computer and experimental analysis.

Authors:  J L Tsao; S D Davis; S M Baker; R M Liskay; D Shibata
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Molecular tumor clocks and dynamic phenotype.

Authors:  D Shibata
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

3.  Anticipation in lynch syndrome: where we are where we go.

Authors:  Cristina Bozzao; Patrizia Lastella; Alessandro Stella
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.